Evidence map›Paper›PMID 33277367›Full record

ArticleCancer research2021

ATG5-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia.

Katherine Oravecz-Wilson, Corinne Rossi, Cynthia Zajac, Yaping Sun, Lu Li, Thomas Decoville, Hideaki Fujiwara, Stephanie Kim, Daniel Peltier, Pavan Reddy

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. The Role of Autophagy in the Function of CD4Frontiers in pharmacology · 2022
    Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Katherine Oravecz-Wilson *Department of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Corinne Rossi *Department of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Cynthia ZajacDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Yaping SunDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Lu LiDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID https://orcid.org/0000-0002-5496-7837
Thomas DecovilleDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Hideaki FujiwaraDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Stephanie KimDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Daniel PeltierDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.ORCID https://orcid.org/0000-0001-6069-9894
Pavan ReddyDepartment of Internal Medicine, Division of Hematology and Oncology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan. reddypr@med.umich.edu.
Michigan Medicine · US

Funding

TUMOR VACCINES AND BONE MARROW TRANSPLANTATIONP01CA039542 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAMES L. M. FERRARA · 1985 to 2026
$47.9M
Metabolomics CoreP01HL149633 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN, TEWARI, MUNEESH · 2020 to 2024
$11.1M
COPII dependent regulation of T cell alloimmunityR01HL152605 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2020 to 2023
$2.4M
Cellular and molecular mechanisms of target tissue resistance for mitigating GVHD severityR01CA203542 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2016 to 2020
$2.4M
Targeting Novel DAMP mediated signaling pathways to mitigate GVHDR01CA217156 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2017 to 2022
$1.9M
Development of a Novel Strategy to Prevent Experimental GVHDR01CA143379 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2010 to 2014
$739k
NCI NIH HHS P01 CA039542NCI NIH HHS R01 CA143379NCI NIH HHS R01 CA203542NCI NIH HHS R01 CA217156NHLBI NIH HHS P01 HL149633NHLBI NIH HHS R01 HL152605
6 · The paper itself

Abstract

Autophagy is a vital cellular process whose role in T immune cells is poorly understood, specifically, in its regulation of allo-immunity. Stimulation of wild-type T cells

Indexed as

AnimalsAutophagy-Related Protein 5Cell ProliferationCells, CulturedGraft vs Host DiseaseGraft vs Leukemia EffectHumansLymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutT-LymphocytesATG5 protein, humanAtg5 protein, mouseAutophagy-Related Protein 5

Identifiers

PMID33277367
PMCPMC9400550
OpenAlexW3108858581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.